Pages that link to "Q34553316"
Jump to navigation
Jump to search
The following pages link to Metabolism and disposition of vatalanib (PTK787/ZK-222584) in cancer patients (Q34553316):
Displaying 17 items.
- Recent developments in receptor tyrosine kinases targeted anticancer therapy (Q26751331) (← links)
- Progress on antiangiogenic therapy for patients with malignant glioma (Q33773189) (← links)
- New approaches in angiogenic targeting for colorectal cancer. (Q34382785) (← links)
- Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance) (Q34570873) (← links)
- 2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib. (Q35786901) (← links)
- Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma (Q37214249) (← links)
- Moving towards dose individualization of tyrosine kinase inhibitors (Q37787577) (← links)
- Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals (Q37882685) (← links)
- Role of tyrosine kinase inhibitors in the management of high-grade gliomas (Q37952242) (← links)
- Bioanalytical Aspects of Clinical Mass Balance Studies in Oncology (Q37963912) (← links)
- Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors. (Q38552109) (← links)
- Synthesis and Cytotoxic Evaluation of Some New Phthalazinylpiperazine Derivatives (Q39456618) (← links)
- Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses (Q39560865) (← links)
- Issues in the Safety Testing of Metabolites (Q39934028) (← links)
- A phase I trial of PTK787/ZK222584 in combination with pemetrexed and cisplatin in patients with advanced solid tumors (Q46472676) (← links)
- Inhibitory Effects of Red Wine on Lipid Oxidation in Fish Oil Emulsion and Angiogenesis in Zebrafish Embryo (Q50216641) (← links)
- A Study of Pipeline Drugs in Neuroendocrine Tumors (Q84070923) (← links)